今日の臨床サポート 今日の臨床サポート
関連論文:
img  1:  Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization.
 
著者: S F Kemp, R F Lockey, F E R Simons, World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis
雑誌名: Allergy. 2008 Aug;63(8):1061-70. doi: 10.1111/j.1398-9995.2008.01733.x.
Abstract/Text Anaphylaxis is an acute and potentially lethal multi-system allergic reaction. Most consensus guidelines for the past 30 years have held that epinephrine is the drug of choice and the first drug that should be administered in acute anaphylaxis. Some state that properly administered epinephrine has no absolute contraindication in this clinical setting. A committee of anaphylaxis experts assembled by the World Allergy Organization has examined the evidence from the medical literature concerning the appropriate use of epinephrine for anaphylaxis. The Committee strongly believes that epinephrine is currently underutilized and often dosed suboptimally to treat anaphylaxis, is under-prescribed for potential future self-administration, that most of the reasons proposed to withhold its clinical use are flawed, and that the therapeutic benefits of epinephrine exceed the risk when given in appropriate i.m. doses.

PMID 18691308  Allergy. 2008 Aug;63(8):1061-70. doi: 10.1111/j.1398-9995.2008.01733.x.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから